netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
 Formulary Chapter 14: Immunological products and vaccines - Full Chapter
Notes:

Prescribing Guidance

Please see our Prescribing Guidelines page for all prescribing guidance relating to this chapter.

Shared Care Agreements

There are no Shared Care Agreements relating to this chapter.

 

Chapter Links...
 Details...
14.04  Expand sub section  Vaccines and antisera
14.04  Expand sub section  Anthrax vaccine
14.04  Expand sub section  BCG vaccines
14.04  Expand sub section  Botulism antitoxin
14.04  Expand sub section  Cholera vaccine to top
14.04  Expand sub section  Diphtheria vaccines
14.04  Expand sub section  Haemophilus influenzae type B vaccine
14.04  Expand sub section  Hepatitis A vaccine
14.04  Expand sub section  Hepatitis B vaccine
14.04  Expand sub section  Human papilloma virus vaccine to top
14.04  Expand sub section  Influenza vaccine
14.04  Expand sub section  Measles vaccine
14.04  Expand sub section  Measles, Mumps and Rubella (MMR) vaccine
14.04  Expand sub section  Meningococcal vaccines
14.04  Expand sub section  Mumps vaccine to top
14.04  Expand sub section  Pertussis vaccine
14.04  Expand sub section  Pneumococcal vaccines
14.04  Expand sub section  Poliomyelitis vaccines
14.04  Expand sub section  Rabies vaccine
14.04  Expand sub section  Rotavirus vaccine to top
14.04  Expand sub section  Rubella vaccine
14.04  Expand sub section  Smallpox vaccine
14.04  Expand sub section  Tetanus vaccines
14.04  Expand sub section  Tick-borne encephalitis vaccine
14.04  Expand sub section  Typhoid vaccines to top
14.04  Expand sub section  Varicella-zoster vaccine
Varicella Zoster vaccine
(Zostavax)
View adult BNF View SPC online
Formulary
traffic lightGreen
  • The aim of the national shingles immunisation programme is to lower the incidence and severity of shingles in older people. It is recommended that it be routinely offered to people aged 70 years.
  • Whilst the vaccine is authorised for use from age 50 years and is effective in this age group, the burden of shingles disease is generally not as severe in those aged 50-69 years when compared with older ages. Furthermore, given that the duration of protection is not known to last for more than ten years and the need for a second dose is not known, the vaccine is not recommended to be offered routinely below 70 years of age. Administration after 80 years of age is less cost-effective due to the limited effectiveness of the vaccine in older individuals.
 
Link  Green Book - Chapter 28a
 
Varicella-zoster vaccine
(Varilrix)
View adult BNF View SPC online
Formulary
traffic lightGreen
  • Varilrix is indicated for active immunisation against varicella of healthy subjects (from the age of 9 months).
  • Vaccination of susceptible healthy close contacts of subjects at risk of severe varicella is recommended, in order to reduce the risk of transmission of wild-type virus to these patients. Close contacts include parents and siblings of high-risk patients, and medical and paramedical personnel.
  • Use as per green book only.
 
Link  Green Book - Chapter 34
 
Varicella-zoster vaccine
(Varivax)
View adult BNF View SPC online
Formulary
traffic lightGreen
  • VARIVAX is indicated for vaccination against varicella in individuals from 12 months of age.
  • VARIVAX can be administered to infants from 9 months of age under special circumstances, such as to conform with national vaccination schedules or in outbreak situations.
  • VARIVAX may also be administered to susceptible individuals who have been exposed to varicella. Vaccination within 3 days of exposure may prevent a clinically apparent infection or modify the course of the infection. In addition, there are limited data that indicate that vaccination up to 5 days after exposure may modify the course of the infection
  • Use as per green book only.
 
Link  Green Book - Chapter 34
 
14.04  Expand sub section  Yellow fever vaccine
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Traffic LightRed

RED - Hospital only to be prescribed by a specialist and supplied from secondary care ONLY throughout treatment.  

Traffic LightAmber

Amber medicines are considered suitable for GP prescribing following specialist initiation or recommendation.  

Traffic LightAmber with Shared Care

Shared Care - these medicines require specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.  

Traffic LightGreen

These medicines are appropriate for initiation in both primary and secondary care. Prescribing is appropriate within licensed or local recommendations.  

Traffic LightSelf

Suitable for patient to be directed to buy themselves  

Traffic LightGrey

Not currently used. We intend to include this TLS in future to highlight where a decision to use this medicine is under review.   

Traffic LightBlack

(In use from Oct 2020) Used where a decision has been made by the BSW APC not to routinely commission this preparation for its licensed indications. Do not prescribe.   

Traffic LightRed Specialist Centre

Not currently used. We intend to include this TLS in future to highlight where this medicine and indication is ONLY available through a Specialist Centre according to a NICE Highly Specialised Technology or NHSE Specialised Commission Circular / Policy.  

netFormulary